Etrolizumab in moderate-to-severe ulcerative colitis

Alessandro Armuzzi; Carla Felice

doi:10.1016/S0140-6736(14)60529-8

Etrolizumab in moderate-to-severe ulcerative colitis

Alessandro Armuzzi
, Carla Felice

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo

6 Citazioni (Scopus)

Abstract

no abstract available

Lingua originale	Inglese
pagine (da-a)	285-286
Numero di pagine	2
Rivista	THE LANCET
Volume	384
DOI	https://doi.org/10.1016/S0140-6736(14)60529-8
Stato di pubblicazione	Pubblicato - 2014

Keywords

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Colitis, Ulcerative
Female
Humans
Male

Accesso al documento

10.1016/S0140-6736(14)60529-8

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{8f817244dea143c5b81c3e8bca9219c7,

title = "Etrolizumab in moderate-to-severe ulcerative colitis",

abstract = "no abstract available",

keywords = "Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Colitis, Ulcerative, Female, Humans, Male, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Colitis, Ulcerative, Female, Humans, Male",

author = "Alessandro Armuzzi and Carla Felice",

year = "2014",

doi = "10.1016/S0140-6736(14)60529-8",

language = "English",

volume = "384",

pages = "285--286",

journal = "THE LANCET",

issn = "0099-5355",

publisher = "The Lancet:6277 Sea Harbor:Orlando, FL 32887:(800)462-6198, EMAIL: [email protected], INTERNET: http://www.thelancet.com, Fax: (407)363-1354",

}

TY - JOUR

T1 - Etrolizumab in moderate-to-severe ulcerative colitis

AU - Armuzzi, Alessandro

AU - Felice, Carla

PY - 2014

Y1 - 2014

N2 - no abstract available

AB - no abstract available

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Colitis, Ulcerative

KW - Female

KW - Humans

KW - Male

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Colitis, Ulcerative

KW - Female

KW - Humans

KW - Male

UR - http://hdl.handle.net/10807/64544

U2 - 10.1016/S0140-6736(14)60529-8

DO - 10.1016/S0140-6736(14)60529-8

M3 - Article

SN - 0099-5355

VL - 384

SP - 285

EP - 286

JO - THE LANCET

JF - THE LANCET

ER -

Etrolizumab in moderate-to-severe ulcerative colitis

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo